Elena Belitsky

Director, Analytical Development at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Elena Belitsky's Colleagues at Alnylam Pharmaceuticals
Heather Sun

Sr Director, Medical Information & Review, Medical Affairs

Contact Heather Sun

Michael Battersby

Director External Quality Assurance (RM/API/DP/Audit/QC)

Contact Michael Battersby

Kirk Brown

Senior Director, CNS Research

Contact Kirk Brown

John Tukianen

Senior Engineer, External Manufacturing Technical Services

Contact John Tukianen

Thierry Auperin

Vice President, Medical Communication and Training

Contact Thierry Auperin

Melinda Baker

Associate Director, Global Marketing

Contact Melinda Baker

View All Elena Belitsky's Colleagues
Elena Belitsky's Contact Details
HQ
(617) 551-8200
Location
Greater Boston
Company
Alnylam Pharmaceuticals
Elena Belitsky's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Elena Belitsky
Elena Belitsky currently works for Alnylam Pharmaceuticals.
Elena Belitsky's role at Alnylam Pharmaceuticals is Director, Analytical Development.
Elena Belitsky's email address is ***@alnylam.com. To view Elena Belitsky's full email address, please signup to ConnectPlex.
Elena Belitsky works in the SaaS industry.
Elena Belitsky's colleagues at Alnylam Pharmaceuticals are Heather Sun, Michelle Mitchell, Michael Battersby, Kirk Brown, John Tukianen, Thierry Auperin, Melinda Baker and others.
Elena Belitsky's phone number is (617) 551-8200
See more information about Elena Belitsky